Mode
Text Size
Log in / Sign up
N/A N=304 Randomized Single-blind Treatment

Trial of Collaborative Depression Care Management for HIV Patients

Depression · HIV

Enrolled (actual)
304
Serious AEs
1.0%
Results posted
Oct 2016
Primary outcome: Primary: Antiretroviral Medication Adherence — 89.2; 87.6 observed pills taken as % of expected

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Measurement-Based Care collaborative depression management (Other); Enhanced Usual Care (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Duke University
Primary completion
Apr 2014

Outcome Measures

OutcomeResultp-value
PRIMARY
Antiretroviral Medication Adherence
86.3; 94.5
SECONDARY
Depressive Symptoms
13.5; 17.2
SECONDARY
Antiretroviral Medication Adherence
86.3; 94.5
SECONDARY
Health Care Costs
4611; 4535
SECONDARY
Appointment Adherence
81.3; 80.1
SECONDARY
Number of Participants With Viral Load Below Detection
68; 75
SECONDARY
Quality of Life
41.6; 37.6
SECONDARY
Self Reported Adherence
92.7; 93.9
SECONDARY
Self-reported Adherence
91.6; 94.1
SECONDARY
Safety Endpoint
2; 4
SECONDARY
Depression-free Days
160; 136

Summary

This project will integrate a depression treatment and brief medication adherence counseling intervention into clinical care at three HIV clinics and will use a randomized controlled trial to assess whether, relative to usual care, the intervention leads to improved HIV medication adherence. The depression treatment intervention uses a model known as Measurement-Based Care which equips Depression Care Managers with systematic measurement tools, a decision algorithm, and psychiatric backup and trains them to provide decision support to HIV clinicians to implement, monitor, and adjust antidepressant therapy.

Eligibility Criteria

Inclusion Criteria

  • Age 18-65
  • HIV-positive
  • Patient Health Questionnaire-9 (PHQ-9) total score >= 10
  • Confirmed current major depressive episode
  • English-speaking

Exclusion Criteria

  • History of bipolar disorder
  • History of psychotic disorder
  • Failure of adequate trials of two different antidepressants at effective doses in the current depressive episode
  • Current substance dependence requiring inpatient hospitalization
  • Not mentally competent
  • Acute suicidality or other psychiatric presentation requiring immediate hospitalization
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01372605). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search